Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?;¿Test químico o test inmunológico para la detección de sangre oculta en heces en el cribado del cáncer colorrectal?

Gastroenterologia y Hepatologia

Volumn 32, Issue 8, 2009, Pages 565-576

  Quintero, Enrique ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Chemical test; Colorectal cancer screening; Fecal occult blood; Guaiac; Immunological test

Indexed keywords

HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHEMICAL ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOLOGICAL TECHNIQUE; MALE; NON INVASIVE PROCEDURE; OCCULT BLOOD; QUALITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

CHEMISTRY TECHNIQUES, ANALYTICAL; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FECES; HEMOGLOBINS; HUMANS; IMMUNOLOGIC TESTS; OCCULT BLOOD;

EID: 69949085782     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.01.179     Document Type: Article

References (53)

1. Recommendations on cancer screening in the European Union. Advisory Committee on Cancer Prevention. Eur J Cancer 36 (2000) 1473-1478
2. Estrategia en cáncer del sistema nacional de salud. Líneas estratégicas priorizadas: objetivos, acciones e indicadores (2006-2008). Madrid: Ministerio de Sanidad y Consumo; 2005.
3. Young G.P., St John D.J., Winawer S.J., and Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies: A WHO (World Health Organization) and WODE (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97 (2002) 2499-2507
4. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
5. Scholefield J.H., Moss S., Sufi F., Mangham C.M., and Hardcastle J.D. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 50 (2002) 840-844
6. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
7. Kronborg O., Jorgensen O.D., Fenger C., and Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 39 (2004) 846-851
8. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al., Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
9. Mandel J.S., Church T.R., Ederer F., and Bond J.H. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91 (1999) 434-437
10. Kewenter J., Brevinge H., Engaras B., Haglind E., and Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 29 (1994) 468-473
11. Lindholm E., Brevinge H., and Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 95 (2008) 1029-1036
12. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
13. Fraser C.G., Mathew C.M., Mowat N.A., Wilson J.A., Carey F.A., and Steele R.J. Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach. Gut 56 (2007) 1415-1418
14. Fraser C.G., Matthew C.M., Mowat N.A., Wilson J.A., Carey F.A., and Steele R.J. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: An observational study. Lancet Oncol 7 (2006) 127-131
15. St John D.J., Young G.P., Alexeyeff M.A., Deacon M.C., Cuthbertson A.M., Macrae F.A., et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104 (1993) 1661-1668
16. Levin B., Hess K., and Johnson C. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Arch Intern Med 157 (1997) 970-976
17. Feinberg E.J., Steinberg W.M., Banks B.L., and Henry J.P. How long to abstain from eating red meat before fecal occult blood tests. Ann Intern Med 113 (1990) 403-404
18. Rozen P., Knaani J., and Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 44 (1999) 756-760
19. Sinatra M.A., St John D.J., and Young G.P. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clin Chem 45 (1999) 123-126
20. Pignone M., Campbell M.K., Carr C., and Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 4 (2001) 150-156
21. Rozen P., Knaani J., and Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 42 (1997) 2064-2071
22. Allison J.E. Review article: Faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 12 (1998) 1-10
23. Jaffe R.M., Kasten B., Young D.S., and MacLowry J.D. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 83 (1975) 824-826
24. Castiglione G., Sala P., Ciatto S., Grazzini G., Mazzotta A., Rossetti C., et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev 3 (1994) 399-405
25. Allison J.E., Sakoda L.C., Levin T.R., Tucker J.P., Tekawa I.S., Cuff T., et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 99 (2007) 1462-1470
26. Smith A., Young G.P., Cole S.R., and Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107 (2006) 2152-2159
27. Van Rossum L.G., Van Rijn A.F., Laheij R.J., Van Oijen M.G., Fockens P., Van Krieken H.H., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135 (2008) 82-90
28. Morikawa T., Kato J., Yamaji Y., Wada R., Mitsushima T., and Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428
29. Vilkin A., Rozen P., Levi Z., Waked A., Maoz E., Birkenfeld S., et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100 (2005) 2519-2525
30. Mant J. Is the test effective?. In: Dawes M., Davies P., Gray A., et al. (Eds). Evidence-based practice (1999), Churchill Livingstone, Toronto 133-137
31. Sasse E.A. Objective evaluation of data in screening for disease. Clin Chim Acta 315 (2002) 17-30
32. Petrelli N., Michalek A.M., Freedman A., Baroni M., Mink I., and Rodriguez-Bigas M. Immunochemical versus guaiac occult blood stool tests: Results of a community-based screening program. Surg Oncol 3 (1994) 27-36
33. Allison J.E., Tekawa I.S., Ransom L.J., and Adrain A.L. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334 (1996) 155-159
34. Levi Z., Rozen P., Hazazi R., Vilkin A., Waked A., Maoz E., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146 (2007) 244-255
35. Ciatto S., Martinelli F., Castiglione G., Mantellini P., Rubeca T., Grazzini G., et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 96 (2007) 218-221
36. Nakama H., Zhang B., and Zhang X. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 37 (2001) 398-401
37. Ransohoff D.F. Lessons from the UK sigmoidoscopy screening trial. Lancet 359 (2002) 1266-1267
38. Hewitson P., Glasziou P., Watson E., Towler B., and Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 103 (2008) 1541-1549
39. Moayyedi P., and Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 101 (2006) 380-384
40. Whitlock E.P., Lin J.S., Liles E., Beil T.L., and Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med 149 (2008) 638-658
41. Nakajima M., Saito H., Soma Y., Sobue T., Tanaka M., and Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: A case-control study. Br J Cancer 89 (2003) 23-28
42. Burch J.A., Soares-Weiser K., St John D.J., Duffy S., Smith S., Kleijnen J., et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: A systematic review. J Med Screen 14 (2007) 132-137
43. Castiglione G., Zappa M., Grazzini G., Mazzotta A., Biagini M., Salvadori P., et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 74 (1996) 141-144
44. Dancourt V., Lejeune C., Lepage C., Gailliard M.C., Meny B., and Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 44 (2008) 2254-2258
45. Guittet L., Bouvier V., Mariotte N., Vallee J.P., Arsene D., Boutreux S., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56 (2007) 210-214
46. Quintero E.G.-G.Z., Parra-Blanco A., Nicolás-Pérez D., García M., Moreno S., Jiménez J., et al. One-time screening with an immunochromatografic occult blood test predicts the detection of advanced adenoma and colorectal cancer in the average-risk population. Can J Gastroenterol 19 (2005) 21B
47. Zappa M., Castiglione G., Paci E., Grazzini G., Rubeca T., Turco P., et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: The district of Florence experience. Int J Cancer 92 (2001) 151-154
48. Rozen P., Levi Z., Hazazi R., Waked A., Vilkin A., Maoz E., et al. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Aliment Pharmacol Ther 29 (2009) 450-457
49. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: A pilot study. Eur J Gastroenterol and Hepatol. En prensa 2009.
50. Graser A., Stieber P., Nagel D., Schafer C., Horst D., Becker C.R., et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 58 (2009) 241-248
51. Shapiro J.A., Seeff L.C., Thompson T.D., Nadel M.R., Klabunde C.N., and Vernon S.W. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 17 (2008) 1623-1630
52. Segnan N., Senore C., Andreoni B., Azzoni A., Bisanti L., Cardelli A., et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132 (2007) 2304-2312
53. Cole S.R., Young G.P., Esterman A., Cadd B., and Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 10 (2003) 117-122